Document is current
Any future updates will be listed below
-
Authors
Wen, Ji
Rusch, Michael
Brady, Samuel W.
Shao, Ying
Edmonson, Michael N.
Shaw, Timothy I.
Powers, Brent B.
Tian, Liqing
Easton, John
Mullighan, Charles G.
Gruber, Tanja
Ellison, David
Zhang, Jinghui https://orcid.org/0000-0003-3350-9682
-
Funding
Funding for this research was provided by:
national institutes of health (P30CA021765)
american lebanese syrian associated charities
- License Information
-
More Information
Article History
Received: 8 August 2021
Accepted: 2 November 2021
First Online: 17 November 2021
Declarations
:
: PCGP cancer and matched normal samples were obtained under written informed consent which was provided by a parent or guardian of each child, or by patients themselves if 18 years of age or older. This study was approved by the institutional review board at St. Jude Children’s Research Hospital.
: Not applicable.
: CGM has received consulting and speaking fees from Illumina and Amgen, and research support from Loxo Oncology, Pfizer and Abbvie, and holds stock in Amgen.
